Forster, V. J., van Delft, F. W., Baird, S. F., Mair, S., Skinner, R. and Halsey, C. (2016) Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients. Cancer Chemotherapy and Pharmacology, 78(5), pp. 1093-1096. (doi: 10.1007/s00280-016-3153-0) (PMID:27659182) (PMCID:PMC5083755)
|
Text
129126.pdf - Published Version Available under License Creative Commons Attribution. 454kB |
Abstract
Purpose: Methotrexate administration is associated with frequent adverse neurological events during treatment for childhood acute lymphoblastic leukemia. Here, we present evidence to support the role of common drug interactions and low vitamin B12 levels in potentiating methotrexate neurotoxicity. Methods: We review the published evidence and highlight key potential drug interactions as well as present clinical evidence of severe methotrexate neurotoxicity in conjunction with nitrous oxide anesthesia and measurements of vitamin B12 levels among pediatric leukemia patients during therapy. Results: We describe a very plausible mechanism for methotrexate neurotoxicity in pediatric leukemia patients involving reduction in methionine and consequential disruption of myelin production. We provide evidence that a number of commonly prescribed drugs in pediatric leukemia management interact with the same folate biosynthetic pathways and/or reduce functional vitamin B12 levels and hence are likely to increase the toxicity of methotrexate in these patients. We also present a brief case study supporting out hypothesis that nitrous oxide contributes to methotrexate neurotoxicity and a nutritional study, showing that patients. Conclusions: Use of nitrous oxide in pediatric leukemia patients at the same time as methotrexate use should be avoided especially as many suitable alternative anesthetic agents exist. Clinicians should consider monitoring levels of vitamin B12 in patients suspected of having methotrexate- induced neurotoxic effects.
Item Type: | Articles |
---|---|
Additional Information: | This work was supported by the JGW Patterson Foundation, Newcastle upon Tyne, UK, (VF) and Children with Cancer UK (CH). |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Halsey, Professor Chris |
Authors: | Forster, V. J., van Delft, F. W., Baird, S. F., Mair, S., Skinner, R., and Halsey, C. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | Cancer Chemotherapy and Pharmacology |
Publisher: | Springer |
ISSN: | 0344-5704 |
ISSN (Online): | 1432-0843 |
Published Online: | 22 September 2016 |
Copyright Holders: | Copyright © 2016 The Authors |
First Published: | First published in Cancer Chemotherapy and Pharmacology 78(5):1093-1096 |
Publisher Policy: | Reproduced under a creative commons license |
University Staff: Request a correction | Enlighten Editors: Update this record